全文获取类型
收费全文 | 88215篇 |
免费 | 7644篇 |
国内免费 | 5481篇 |
专业分类
耳鼻咽喉 | 954篇 |
儿科学 | 925篇 |
妇产科学 | 636篇 |
基础医学 | 9410篇 |
口腔科学 | 1397篇 |
临床医学 | 10029篇 |
内科学 | 11427篇 |
皮肤病学 | 980篇 |
神经病学 | 3903篇 |
特种医学 | 3955篇 |
外国民族医学 | 21篇 |
外科学 | 10913篇 |
综合类 | 17476篇 |
现状与发展 | 19篇 |
一般理论 | 3篇 |
预防医学 | 6315篇 |
眼科学 | 1821篇 |
药学 | 9193篇 |
77篇 | |
中国医学 | 5299篇 |
肿瘤学 | 6587篇 |
出版年
2024年 | 234篇 |
2023年 | 1070篇 |
2022年 | 2688篇 |
2021年 | 3619篇 |
2020年 | 2853篇 |
2019年 | 2353篇 |
2018年 | 2553篇 |
2017年 | 2533篇 |
2016年 | 2545篇 |
2015年 | 3940篇 |
2014年 | 4978篇 |
2013年 | 5210篇 |
2012年 | 7590篇 |
2011年 | 7905篇 |
2010年 | 5939篇 |
2009年 | 5015篇 |
2008年 | 5755篇 |
2007年 | 5571篇 |
2006年 | 5281篇 |
2005年 | 4579篇 |
2004年 | 3432篇 |
2003年 | 3339篇 |
2002年 | 2932篇 |
2001年 | 2195篇 |
2000年 | 1615篇 |
1999年 | 1198篇 |
1998年 | 695篇 |
1997年 | 701篇 |
1996年 | 496篇 |
1995年 | 420篇 |
1994年 | 395篇 |
1993年 | 222篇 |
1992年 | 228篇 |
1991年 | 230篇 |
1990年 | 192篇 |
1989年 | 148篇 |
1988年 | 137篇 |
1987年 | 126篇 |
1986年 | 99篇 |
1985年 | 92篇 |
1984年 | 34篇 |
1983年 | 29篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1980年 | 11篇 |
1979年 | 28篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1975年 | 9篇 |
1974年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
社会力量具备相应的经济基础和技术条件,对于公立互联网医院体系建设具有积极的促进作用。但是实践中仍然存在商业模式不完善、监管制度不健全等问题。基于经济学契约理论要义,提出在坚持激励与约束机制并举、平衡公私益关系的前提下,通过完善医保政策、构建互联网医疗服务价格分类管理机制来促进社会力量向医疗服务公益性目标回归,并通过构建完善的监督体制来约束部分社会力量的盲目逐利性行为。 相似文献
2.
3.
Wuteng Cao Huabin Hu Jiao Li Qianyu Wu Lishuo Shi Biao Li Jie Zhou Xinhua Wang Junhong Chen Chao Wang Huaiming Wang Weihao Deng Yan Huang Yanhong Deng 《International journal of cancer. Journal international du cancer》2023,153(11):1894-1903
Neoadjuvant programmed cell death protein 1 (PD-1) blockade exhibits promising efficacy in patients with mismatch repair deficient (dMMR) colorectal cancer (CRC). However, discrepancies between radiological and histological findings have been reported in the PICC phase II trial (NCT 03926338). Therefore, we strived to discern radiological features associated with pathological complete response (pCR) based on computed tomography (CT) images. Data were obtained from the PICC trial that included 36 tumors from 34 locally advanced dMMR CRC patients, who received neoadjuvant PD-1 blockade for 3 months. Among the 36 tumors, 28 (77.8%) tumors achieved pCR. There were no statistically significant differences in tumor longitudinal diameter, the percentage change in tumor longitudinal diameter from baseline, primary tumor sidedness, clinical stage, extramural venous invasion status, intratumoral calcification, peritumoral fat infiltration, intestinal fistula and tumor necrosis between the pCR and non-pCR tumors. Otherwise, tumors with pCR had smaller posttreatment tumor maximum thickness (median: 10 mm vs 13 mm, P = .004) and higher percentage decrease in tumor maximum thickness from baseline (52.9% vs 21.6%, P = .005) compared to non-pCR tumors. Additionally, a higher proportion of the absence of vascular sign (P = .003, odds ratio [OR] = 25.870 [95% CI, 1.357-493.110]), nodular sign (P < .001, OR = 189.000 [95% CI, 10.464-3413.803]) and extramural enhancement sign (P = .003, OR = 21.667 [2.848-164.830]) was observed in tumors with pCR. In conclusion, these CT-defined radiological features may have the potential to serve as valuable tools for clinicians in identifying patients who have achieved pCR after neoadjuvant PD-1 blockade, particularly in individuals who are willing to adopt a watch-and-wait strategy. 相似文献
4.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
5.
Zeyu Li Erwei Hao Rui Cao Si Lin Linghui Zou Tianyan Huang Zhengcai Du Xiaotao Hou Jiagang Deng 《中草药(英文版)》2022,14(4):479-493
Zedoary tumeric (Curcumae Rhizoma, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The anti liver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the anti hepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an anti hepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an anti hepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group". 相似文献
6.
目的 运用CT区分脾脏血管性病变与淋巴瘤。方法 回顾性分析20例经手术、穿刺病理学检查证实的脾脏病变的发病年龄、性别、脾脏指数、病变大小、数目、有无液化、钙化、强化幅度、强化方式等特征,并进行统计学分析。结果 20例脾脏病变中,11例血管性病变(6例海绵状血管瘤,3例窦岸细胞血管瘤,2例硬化性血管瘤样结节性转化),9例淋巴瘤;两组间发病年龄、病变大小、数目、有无液化、钙化等差异无统计学意义;两组间脾脏指数、动脉期强化幅度差异具有统计学意义(P<0.05)。5例海绵状血管瘤呈不均匀性强化,1例呈渐进性填充式强化,2例窦岸细胞血管瘤呈“雀斑征”,1例硬化性血管瘤样结节性转化呈“辐轮征”;9例淋巴瘤实质部分均呈均匀、轻中度强化。结论 脾脏血管性病变与淋巴瘤CT表现不同,CT有助于明确诊断。 相似文献
7.
8.
<正>随着科技的进步,医疗技术的不断提高,使得诸多影像学检查在临床疾病诊断和治疗工作中发挥了重要作用。20世纪90年代末推出了数字X线成像(digital radiography,DR)成像系统,DR数字影像具有成像质量高,成像速度快,辐射剂量小等优点通过该系统,可以直接将X线信号转换为数字信号,既缩短了拍摄时间,同时由于自带显示系统,医生可以第一时间获得有关患者病情的清晰影像资料,这对于 相似文献
9.
10.